StockData
Curis Inc logo

Curis Inc (CRIS) stock

CRISNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3092% below fair value
$0.54+0.11 (+24.32%)

Close on Nov 17, 2026Market cap $1.13MP/E –Yield –

Curis price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Curis's price to book ratio was 0.2× on Nov 11, 2026, against 6.5× a year earlier. Over the last 5 years it ranged from 0.2× to 49.5×, with a median of 2.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.2×−3.2
2024Jul 31, 20243.4×+0.9
2023Dec 29, 20232.5×+1.6
2022Dec 30, 20221.0×−3.3
2021Dec 31, 20214.2×−45.3
2019Jan 31, 201949.5×+20.3
2018Dec 31, 201829.2×+25.4
2017Dec 29, 20173.8×−7.6
2016Dec 30, 201611.4×+6.5
2015Dec 31, 20154.9×+1.2
2014Dec 31, 20143.7×−2.0
2013Dec 31, 20135.7×−0.3
2012Dec 31, 20126.0×−5.1
2011Dec 30, 201111.1×–

More Curis figures

See a number that looks wrong?